معرفی
Dr. Nimesh Mody is a Senior Lecturer at the University of Aberdeen, affiliated with the School of Medicine, Medical Sciences and Nutrition and the Aberdeen Cardiovascular & Diabetes Centre. He holds a PhD in Biochemistry from the University of Dundee (2003) and a BSc in Biochemistry from University College London (1998 with First Class Honours). His research focuses on obesity, insulin resistance, and cardiometabolic diseases, particularly exploring retinoid homeostasis and molecular pathways in metabolic disorders.
Dr. Mody leads research on how high-fat diets trigger obesity-related comorbidities like diabetes and cardiovascular disease. He investigates Fenretinide’s role in reducing liver steatosis and its dual effects on ceramide-induced atherosclerosis. Collaborations include work with Prof. Mirela Delibegovic on PTP1B signaling and Prof. Bettina Platt on Alzheimer’s disease models. His lab employs mouse models, RNA-seq, lipidomic analysis, and clinical trial approaches.
Teaching responsibilities include modules in molecular control of cell function, energy metabolism, and physiology. He coordinates the MSc Cardiovascular Science and Diabetes program. Awards include British Heart Foundation and Wellcome Trust grants, and he guides PhD students like Shehroz Mahmood and Nicola Morrice.
Key contributions include identifying Hsd17b13 as a therapeutic target for fatty liver disease and demonstrating Fenretinide’s impact on retinoid pathways. He also evaluates global health issues, such as diabetes prevalence in rural Uganda during the pandemic, and serves on committees like the Athena SWAN Self-Assessment Team.
